Panel discussion on "Personalized Medicine: New Opportunities in Therapy?"
We are very excited to announce that our lab head Catherine Jutzeler will participate in this panel discussion.
Our lab head Prof. Dr. Catherine Jutzeler along with Myriam DeLeone (General Manager, Amgen Switzerland), Thomas R. Geiger (CEO SPHN) and Simon Hรคfliger (Oncologist) will be participating in this exciting panel discussion.
This event will explore the cutting-edge developments in personalized medicine and their impact on healthcare in Switzerland.
Catherine's contribution will be particularly valuable, given our labโs work in applying data science and AI to enhance patient care. Our research is at the forefront of integrating advanced technologies with medical practice, potentially revolutionizing how we approach personalized treatments.
Discover how personalized medicine and advanced data analytics are revolutionizing healthcare. Explore the ethical challenges, accessibility issues, and data protection concerns in this rapidly evolving field.
๐ฅ๐ฒ๐ด๐ถ๐๐๐ฒ๐ฟ ๐๐ผ๐ฑ๐ฎ๐:
๐ external page https://live.nzz.ch/de/events/nzz-debatte/personalisierte-medizin-neue-chancen-in-der-therapie